- idUS
- Listar por autor
Listar por autor "Isla, Dolores"
Mostrando ítems 1-3 de 3
-
Artículo
Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis
Arriola, Edurne; González Cao, María; Domine, Manuel; De Castro, Javier; Cobo, Manuel; Bernabé-Caro, Reyes; Isla, Dolores (SPRINGER, 2022)Introduction The addition of immune checkpoint inhibitors (ICIs) to conventional chemotherapy (CT) as first-line treatment ...
-
Artículo
Cost-effectiveness of atezolizumab versus pembrolizumab as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in Spain
Isla, Dolores; Lopez-Brea, Marta; Espinosa, María; Arrabal, Natalia; Pérez-Parente, Diego; Carcedo, David; Bernabé-Caro, Reyes (2023)Background Atezolizumab has recently been approved for first-line treatment of high PD-L1 expression metastatic Non-Small-Cell ...
-
Artículo
PD-(L)1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer Patients with High PD-L1 Expression: A Network Meta-Analysis
Majem, Margarita; Cobo, Manuel; Isla, Dolores; Márquez Medina, Diego; Rodríguez Abreu, Delvys; Casal Rubio, Joaquín; Bernabé-Caro, Reyes; Paz-Ares Rodriguez, Luis (MDPI, 2021-03-26)Programmed cell death-ligand 1 (PD-L1) has emerged as a potential biomarker for selection of patients more likely to respond ...